{"slug":"tirzepatide-post-surgery","verification":{"valid":true,"entries":3,"head":"ddacdfcca5e4f0c6bba778a5eded696bd219d139ebb6e58f3affc39eaa1bfd7d"},"count":3,"sources":[{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38430320/","title":"Semaglutide and Tirzepatide for the Management of Weight Recurrence After Sleeve Gastrectomy","quote":"mean post-treatment weight at 6 months ... 15.5 (6.3)% (p < 0.05)","summary":"Retrospective cohort of 115 SG patients; tirzepatide arm showed 15.5% weight loss at 6 months.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:41:59.711Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"f90611de14b38c876ac01a6dab20b0751b9fb5a47f4eaf9620ec8ac5cc27c1fa"},{"id":"s9","type":"pubmed","url":"https://link.springer.com/article/10.1007/s11695-026-08754-7","title":"Tirzepatide for Recurrent Weight Gain after Bariatric Procedures","quote":"mean percentage total body weight loss (%TBWL) was 18.1 ± 5.6% (p < 0.0001)","summary":"Observational cohort of 34 patients post-BS or EBT; 18.1% TBWL at 24 weeks.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:41:59.711Z","link_status":"ok","quote_status":"verified","prev":"f90611de14b38c876ac01a6dab20b0751b9fb5a47f4eaf9620ec8ac5cc27c1fa","hash":"28dcbe9b9125dc5140b2c9f83ef26f8837a96349870bd6af294c396831904312"},{"id":"s5","type":"news","url":"https://publichealth.jhu.edu/2025/one-in-seven-bariatric-surgery-patients-turn-to-new-weight-loss-drugs","title":"One in Seven Bariatric Surgery Patients Turn to New Weight Loss Drugs","quote":"a total of 15,749 patients (14%) began using GLP-1s","summary":"Johns Hopkins analysis of post-bariatric GLP-1 initiation rates.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:41:59.711Z","link_status":"http_403","quote_status":"unverified","prev":"28dcbe9b9125dc5140b2c9f83ef26f8837a96349870bd6af294c396831904312","hash":"ddacdfcca5e4f0c6bba778a5eded696bd219d139ebb6e58f3affc39eaa1bfd7d"}]}